ELUTE fiber provides pharmaceutical, therapeutic, and medical device companies with cutting-edge biodegradable polymers for implantable drug delivery.

TissueGen’s patented extrusion process enables delivery of the broadest range of temperature-sensitive pharmaceuticals and biologics previously impossible to incorporate in implantable devices. In more ways than ever, medical device developers can now deploy advanced drug delivery with ELUTE® fiber – an incredible breakthrough that drastically expands the drugs deliverable via implantable fibers.


ELUTE® Fiber


TissueGen’s ELUTE fiber is ideally suited for a broad range of clinical applications and enables drug delivery from implantable devices for many therapeutic indications.

Advanced Drug Delivery


TissueGen’s patented room temperature fiber extrusion technology  preserves the biological activity of incorporated drugs and enables an entirely new format for drug delivery via biodegradable ELUTE fibers.
Learn More

Nerve Regeneration

Nerve Regeneration

ELUTE fiber is driving a paradigm shift in nerve regeneration through controlled, sustained delivery of sensitive biologics including growth  factors from biomimetic three-dimensional structures.
Learn More

Tissue Engineering


Tailored for devices that require both mechanical and pharmaceutical support,  ELUTE fiber is ideal for tissue scaffolds and stents, including TissueGen’s ARCHER™ stent and drug-eluting stent for the biliary, PAD, and DVT markets.
Learn More


TissueGen’s ELUTE fiber has
won the 2015 R&D 100 Award for
Market Disruptor Services Gold!


Upcoming Events

Recent Awards

Award Finalist

TissueGen is a finalist for the 2017 Future Textiles Award  for Most Innovative Small Company and Best Product – Medical Textiles for its ELUTE® fiber!

Latest News

TissueGen Featured in Nature.com Webcast on Innovations in Drug Delivery Technology
TissueGen’s ELUTE Fiber Provides Controlled Sustained Delivery of Sensitive Drugs Enabling Nerve Regeneration and Tissue Engineering Dallas, TX, March 22, 2017 – TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, nerve regeneration, and tissue engineering, today announced that...
Dr. Lisa A. Fortier Joins TissueGen’s Scientific Advisory Board
Expert in Application of Biologics for Cartilage Repair and Tendinosis Joins Team Pioneering Advances in Drug Delivery, Nerve Regeneration and Tissue Engineering Dallas, TX, February 27, 2017 – TissueGen® Inc., developer of ELUTE® fiber, a groundbreaking biodegradable fiber format for advanced drug delivery, today announced...